Chemoinformaics analysis of Aloe-emodin-glucoside
| Molecular Weight | 432.381 | nRot | 4 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 24 |
| Exact Molecular Weight | 432.106 | nRing | 4 |
| Solubility: LogS | -4.424 | nHRing | 1 |
| Solubility: LogP | 1.563 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 10 | APOL | 56.4259 |
| nHD | 6 | BPOL | 25.2721 |
| QED | 0.306 |
| Synth | 3.846 |
| Natural Product Likeliness | 1.775 |
| NR-PPAR-gamma | 0.796 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.668 |
| Pgp-sub | 0.124 |
| HIA | 0.892 |
| CACO-2 | -5.989 |
| MDCK | 0.00000522 |
| BBB | 0.058 |
| PPB | 0.914223 |
| VDSS | 0.894 |
| FU | 0.0456031 |
| CYP1A2-inh | 0.183 |
| CYP1A2-sub | 0.038 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.149 |
| CYP2c9-sub | 0.062 |
| CYP2d6-inh | 0.167 |
| CYP2d6-sub | 0.138 |
| CYP3a4-inh | 0.136 |
| CYP3a4-sub | 0.09 |
| CL | 4.611 |
| T12 | 0.368 |
| hERG | 0.114 |
| Ames | 0.89 |
| ROA | 0.036 |
| SkinSen | 0.291 |
| Carcinogencity | 0.792 |
| EI | 0.69 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.166 |
| Antiviral | Yes |
| Prediction | 0.917397 |